• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

CooperSurgical

Cooper Companies spends $300M on some Cook Medical product lines

November 1, 2023 By Chris Newmarker

Cook Medical today agreed to sell some reproductive health and otolaryngology product lines to Cooper Cos., the companies announced. The purchase price was $300 million. The products in the sale represent about 2.5% of Cook Medical’s sales. Manufacturing will get transferred to Cooper Cos. over a two-year period. The news comes about three months after […]

Filed Under: Business/Financial News, Featured, Gynecological, Mergers & Acquisitions, News Well, Women's Health Tagged With: Cook Medical, CooperCompanies, CooperSurgical

DTW Podcast: Zimmer Biomet slims, Corza Medical grows in pursuit of grabbing market share

February 8, 2021 By Tom Salemi

In this week’s DeviceTalks Weekly Podcast, Rich Newitter, managing director at SVB Leerink, says Zimmer Biomet’s decision to spin out its spinal and dental business will accelerate its already impressive market share grab in its core orthopedics industry. Newitter says CEO Bryan Hanson brings a tried-and-true diversification model used by companies like his former employer, […]

Filed Under: Dental, Device Talks Podcasts, Digital Health, Featured, Lab Instruments & Supplies, Orthopedics, Spine, Surgical, Wall Street Beat Tagged With: 3m, Abbott, Abbott Laboratories, Aegea Medical, Boston Scientific, CooperSurgical, Corza Medical, Covidien, Medtronic, SVB Leerink, Zimmer Biomet

CooperSurgical acquires Aegea Medical and its water vapor ablation system

February 3, 2021 By Chris Newmarker

CooperCompanies’ (NYSE:COO) CooperSurgical business has purchased Aegea Medical, nearly a year after Aegea secured FDA approval for its Mara water vapor ablation system for treating heavy menstrual bleeding. The financial terms of the deal were not disclosed in the companies’ announcement yesterday. The companies pointed out an international, multi-center pivotal clinical trial enrolling 155 women, […]

Filed Under: Business/Financial News, Featured, Gynecological, Mergers & Acquisitions, Surgical, Women's Health Tagged With: Aegea Medical, aegeamedical, CooperSurgical, The Cooper Cos.

Cooper Cos. shares rise on FY2019 Q1 earnings beat

March 5, 2019 By Fink Densford

Shares in Cooper Cos. (NYSE:COO) have risen in after-hours trading today after the company reported first quarter fiscal year 2019 earnings that beat expectations on Wall Street. The Pleasanton, Calif.-based company reported profits of $103.2 million, or $2.07 per share, on sales of $628.1 million for the three months ended January 31, seeing a swing […]

Filed Under: Business/Financial News, MassDevice Earnings Roundup, Wall Street Beat Tagged With: CooperSurgical, CooperVision, The Cooper Cos.

Teva closes Paragard sale to CooperSurgical

November 2, 2017 By Sarah Faulkner

Teva Pharmaceuticals (NYSE:TEVA) said today that it closed the $1.1 billion cash sale of its Paragard intrauterine copper contraceptive device to Cooper Cos.‘ (NYSE:COO) CooperSurgical unit. The deal included Teva’s manufacturing facility in Buffalo, N.Y., the pharma company reported. The move is part of Teva’s efforts to restructure its business, narrowing its focus on CNS and respiratory […]

Filed Under: Gynecological, Wall Street Beat, Women's Health Tagged With: CooperSurgical, Teva Pharmaceuticals, The Cooper Cos.

Smiths Medical deals Wallace IVF biz to CooperSurgical for $174m

November 9, 2016 By Fink Densford

Smiths Group (LON:SMIN) said today it divested its Wallace in-vitro fertilization product line to Cooper Cos. (NYSE:COO) CooperSurgical subsidiary for $174 million (UK £140 million). The divestiture is part of an ongoing program at Smiths to focus its portfolio on “market leading positions of scale in its chosen markets,” the company said. The company said that proceeds from […]

Filed Under: Business/Financial News, Gynecological, Mergers & Acquisitions Tagged With: CooperSurgical, Smiths Group plc, Smiths Medical, The Cooper Cos.

A medtech veteran takes on C. diff from the gut

November 19, 2015 By Brian Johnson

Most people don’t think much about Clostridium difficile, or C. diff., until it impacts their family. That was the case for Rebiotix CEO Lee Jones, who had never heard of the disease until her mother fell ill with it several years ago. Lee says she quickly learned how dangerous the disease really is – it’s responsible for more than 29,000 […]

Filed Under: Biotech, Device Talks Podcasts Tagged With: CooperSurgical, Inlet Medical, Medtronic, Rebiotix

CooperSurgical pays $47m for IVF screener Reprogenetics

August 17, 2015 By Brad Perriello

Cooper Cos. (NYSE:COO) CooperSurgical subsidiary acquired in-vitro fertilization screening company Reprogenetics last week for nearly $47 million. Livingston, N.J.-based Reprogenetics offers pre-implantation genetic screening and diagnosis for in vitro fertilization, Cooper said. The $46.5 million deal isn’t expected to affect earnings per share this year or in 2016, but should be accretive thereafter, the company said. Reprogenetics put up […]

Filed Under: Diagnostics, Mergers & Acquisitions, Women's Health Tagged With: CooperSurgical, Reprogenetics, The Cooper Cos.

FDA warns CooperSurgical about Texas manufacturing plant

May 30, 2013 By Arezu Sarvestani Leave a Comment

CooperSurgical Logo

The FDA issued a warning to CooperSurgical (NSDQ:COO) after inspectors noted violations at the company’s Stafford, Texas, manufacturing facility.

Filed Under: Food & Drug Administration (FDA), News Well Tagged With: CooperSurgical, The Cooper Cos., Warning Letter

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy